Europe Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and O

Europe Radiation Oncology Market Forecast to 2031 - Regional Analysis - by Types (External Beam Radiation Therapy and Internal Beam Radiation Therapy) and Application (Breast Cancer, Prostate Cancer, Lung Cancer, Head & Neck Cancer, Cervical Cancer, and Others)

The Europe radiation oncology market was valued at US$ 3,317.21 million in 2023 and is expected to reach US$ 8,723.07 million by 2031; it is estimated to record a CAGR of 12.8% from 2023 to 2031.

Initiatives to Support Developments in Radiation Oncology Drive Europe Radiation Oncology Market

The governments and organizations are introducing missions and programs for the quick and effective treatment of cancer with the use of radiotherapy. In September 2023, the International Atomic Energy Agency (IAEA) announced the Rays of Hope-flagship cancer initiative for the development of radiotherapy infrastructure. In developed countries such as the US, Germany, UK, France, and others nearly all patients have access to radiotherapy. In middle-income countries 60% of the patient population and 1 in 10 patients in low-income countries have access to radiotherapy. The Rays of Hope Cancer Care for All focuses on the development of radiotherapy services all over the world. Since, launch of the initiative, various countries have received radiotherapy equipment and training required to operate the equipment for timely diagnosis and treatment. All the five continents are involved in the initiative and contributed US$ 45.5 million (Euro 42 million) for the initiative and the private sector invested US$ 768,902 (Euro 710,000) for support. Moreover, manufacturers such as Elekta signed a partnership with IAEA for the improvement of cancer treatment by providing radiotherapy equipment around the world. Additionally, IAEA started training healthcare professionals from different field this includes 14 radiation oncologist, 13 medical physicist, 4 nuclear medicine technologist, 7 nuclear medicine physician, 7 radiopharmacist, 16 radiation therapy technologist, 7 oncology nurses, 4 medical imaging technologist, and 7 radiologists. Therefore, surging initiatives for radiotherapy is expected to increase the penetration in low-income countries along with trained professionals and development in radiotherapy infrastructure is driving the growth of radiation oncology market in coming years.

Europe Radiation Oncology Market Overview

Germany has an advanced healthcare infrastructure with access to cutting-edge technologies that support the implementation of radiotherapy procedures. The country is also renowned for its strong emphasis on innovation and research. Comprehensive cancer centers operating in Germany provide multidisciplinary treatment plans incorporating radiation therapy, surgery, chemotherapy, and other medical procedures. In 2020, Varian announced that the German Cancer Research Center (DKFZ) in Heidelberg ordered an Adaptive Intelligence solution, the first Ethos therapy in the country. This AI-powered, all-encompassing solution aims to improve the efficacy, adaptability, and capacity of radiotherapy.

Europe Radiation Oncology Market Revenue and Forecast to 2031 (US$ Million)

Europe Radiation Oncology Market Segmentation

The Europe radiation oncology market is categorized into types, application, and country.

Based on type, the Europe radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger market share in 2023.

In terms of application, the Europe radiation oncology market is categorized into breast cancer, prostate cancer, lung cancer, head and neck cancer, cervical cancer, and others. The breast cancer segment held the largest market share in 2023.

By country, the Europe radiation oncology market is segmented into Germany, the UK, France, Spain, Italy, and the Rest of Europe. Germany dominated the Europe radiation oncology market share in 2023.

Varian Medical Systems Inc, Elekta AB, Accuray Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson and Co, Nordion, Mevion Medical Systems, NTP RADIOISOTOPES, Mallinckrodt Plc, and Curium are some of the leading companies operating in the Europe radiation oncology market.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe radiation oncology market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the Europe radiation oncology market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe radiation oncology market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.